| 321638 |
NEURO-ONCOLOGY |
RARE-30. ANAPLASTIC PLEOMORPHIC XANTHOASTROCYTOMA WITH LEPTOMENINGEAL DISSEMINATION RESPONSIVE TO BRAF INHIBITION AND BEVACIZUMAB |
2017-11-01 |
10.1093/neuonc/nox168.874 |
Thomas Alissa, Tucker Suzanne, Nelson Carl, Nickerson Joshua, Durham Susan, Homans Alan |
| 321637 |
NEURO-ONCOLOGY |
ANGI-08. PREDICTING IN VIVO TUMOR GROWTH AND ANGIOGENESIS WITH AN MRI CALIBRATED BIOPHYSICAL MODEL |
2017-11-01 |
10.1093/neuonc/nox168.087 |
Hormuth David, Jarrett Angela, Feng Xinzeng, Yankeelov Thomas |
| 321636 |
NEURO-ONCOLOGY |
NCOG-08. NEUROCOGNITIVE FUNCTIONING IN EORTC BRAIN TUMOR GROUP RANDOMIZED PHASE II TAVAREC TRIAL (EORTC 26091, NCT01164189) ON TEMOZOLOMIDE WITH OR WITHOUT BEVACIZUMAB in 1p/19q INTACT RECURRENT GRADE II AND III GLIOMAS |
2017-11-01 |
10.1093/neuonc/nox168.569 |
Klein Martin, Reijneveld Jaap C, Idbaih Ahmed, Taal Walter, Clement Paul M, de Vos Filip, Wick Antje, Mulholland Paul, Taphoorn Martin J B, Lewis Joanne, Weller Michael, Verschuere Tina, Golfinopoulos Vassilis, Gorlia Thierry, van den Bent Martin |
| 321635 |
NEURO-ONCOLOGY |
IMMU-05. IMMUNE STIMULATION AND IMMUNE CHECKPOINT INHIBITION PROVIDED BY A SINGLE AGENT: AN ONCOLYTIC HSV EXPRESSING A scFv ANTIBODY AGAINST PD-1 |
2017-11-01 |
10.1093/neuonc/nox168.464 |
Passaro Carmela, Alayo Quazim, Nakashima Hiroshi, Chiocca E Antonio |
| 321634 |
BMJ OPEN |
Physical activity in former elite cricketers and strategies for promoting physical activity after retirement from cricket: a qualitative study |
2017-11-01 |
10.1136/bmjopen-2017-017785 |
Filbay Stephanie R, Bishop Felicity L, Peirce Nicholas, Jones Mary E, Arden Nigel K |
| 321633 |
CLINICAL ENDOSCOPY |
Therapy of Pancreatic Neuroendocrine Tumors: Fine Needle Intervention including Ethanol and Radiofrequency Ablation |
2017-11-01 |
|
Sundeep Lakhtakia |
| 321632 |
NEURO-ONCOLOGY |
TMOD-15. TOCA 511 & TOCA FC: PRE-CLINICAL PROOF OF CONCEPT IN CNS METASTATIC BREAST CANCER |
2017-11-01 |
10.1093/neuonc/nox168.1053 |
Inagaki Akihito, Richardson Angela M, Collins Sara A, Hiraoka Kei, Kamijima Shuichi, Shorr Jolene, Gruber Harry, Jolly Douglas, Merchan Jaime, Slingerland Joyce M, Kasahara Noriyuki |
| 321631 |
NEURO-ONCOLOGY |
CMET-49. RECURRENTLY MUTATED GENES DIFFERENTIATE LEPTOMENINGEAL FROM SOLID LUNG CANCER BRAIN METASTASES |
2017-11-01 |
10.1093/neuonc/nox168.195 |
Connolly Ian, Li Yingmei, Liu Boxiang, Gephart Melanie Hayden |
| 321630 |
NEURO-ONCOLOGY |
ATIM-28. IMMUNE PROFILES AT START OF TEMOZOLOMID-BASED STANDARD TREATMENT AND DC-BASED IMMUNOTHERAPY STRONGLY CORRELATE WITH OVERALL SURVIVAL OUTCOME IN GBM PATIENTS |
2017-11-01 |
10.1093/neuonc/nox168.122 |
Antonopoulos Markos, Van Gool Stefaan, Graf Norbert, Stamatakos Georgios |
| 321629 |
NEURO-ONCOLOGY |
IMMU-64. TRIPLE COMBINATION IMMUNOTHERAPY WITH VACCINATION, PD-1 BLOCKADE, AND OX40 LIGATION IS HIGHLY EFFECTIVE AGAINST MURINE INTRACRANIAL GLIOMA |
2017-11-01 |
10.1093/neuonc/nox168.521 |
Jahan Nusrat, Talat Hammad, Saha Dipongkor, Curry William T |
